T. Rowe Price Associates
ETRM

T. Rowe Price Associates’s EnteroMedics Inc. ETRM Stock Holding History

T. Rowe Price Associates’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,674
Closed -$1.09M – 2611
2015
Q2 		$1.09M Sell
1,674
-2,190
-57% -$2.52M ﹤0.01% 1722
2015
Q1 		$3.71M Sell
3,864
-36
-0.9% -$43.4K ﹤0.01% 1505
2014
Q4 		$5.82M Hold
3,900
– – ﹤0.01% 1438
2014
Q3 		$5.04M Buy
3,900
+39
+1% +$57.2K ﹤0.01% 1453
2014
Q2 		$6.33M Sell
3,861
-5
-0.1% -$9.35K ﹤0.01% 1417
2014
Q1 		$7.39M Buy
3,866
+4
+0.1% +$9.47K ﹤0.01% 1365
2013
Q4 		$8.27M Sell
3,862
-19
-0.5% -$30.6K ﹤0.01% 1338
2013
Q3 		$5.09M Hold
3,881
– – ﹤0.01% 1423
2013
Q2 		$4.64M Buy
+3,881
New +$4.1M ﹤0.01% 1420

Other funds holding ETRM

PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
JGC
J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return